Sale!

PSEN1 Gene Alzheimer disease type 3 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “PSEN1 Gene Alzheimer Disease Type 3 Genetic Test” is a specialized diagnostic procedure designed to identify mutations in the PSEN1 gene, which are linked to an increased risk of developing early-onset Alzheimer’s disease, also known as Alzheimer disease type 3. This form of Alzheimer’s disease is hereditary and tends to manifest at a younger age, typically before the age of 65. The PSEN1 gene plays a crucial role in the production of a protein that is part of the process that leads to the accumulation of amyloid plaques, a hallmark of Alzheimer’s disease.

Conducted at DNA Labs UAE, this genetic test is a vital tool for individuals with a family history of early-onset Alzheimer’s disease, providing them with crucial information regarding their genetic predisposition to the condition. By undergoing this test, individuals can make informed decisions about their future health and lifestyle, and in some cases, take preventative measures or plan for early intervention.

The cost of the PSEN1 Gene Alzheimer Disease Type 3 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the testing procedure, analysis, and comprehensive reporting. Given the specialized nature of this test and its significance in potentially altering the course of one’s life, the cost reflects the value of advanced genetic insights into one’s health.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PSEN1 Gene Alzheimer Disease Type 3 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Neurological Disorders

Doctor: Neurologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PSEN1 Gene Alzheimer Disease Type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PSEN1 Gene Alzheimer Disease Type 3.

Test Details

The PSEN1 gene is associated with Alzheimer’s disease type 3, which is an early-onset form of the disease that usually begins before the age of 65. This gene provides instructions for making a protein called presenilin 1, which is involved in the processing of amyloid precursor protein (APP) in the brain.

Mutations in the PSEN1 gene can lead to the production of abnormal forms of APP, which can accumulate in the brain and form plaques that are characteristic of Alzheimer’s disease.

NGS (next-generation sequencing) genetic testing can be used to detect mutations in the PSEN1 gene. This type of testing involves sequencing the entire gene to identify any changes or variations in the DNA sequence that may be associated with Alzheimer’s disease.

NGS testing can be performed using a blood sample or other tissue sample, and can provide a rapid and accurate diagnosis of genetic disorders like Alzheimer’s disease.

Test Name PSEN1 Gene Alzheimer disease type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PSEN1 Gene Alzheimer disease type 3 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with PSEN1 Gene Alzheimer disease type 3
Test Details

The PSEN1 gene is associated with Alzheimer’s disease type 3, which is an early-onset form of the disease that usually begins before the age of 65. This gene provides instructions for making a protein called presenilin 1, which is involved in the processing of amyloid precursor protein (APP) in the brain. Mutations in the PSEN1 gene can lead to the production of abnormal forms of APP, which can accumulate in the brain and form plaques that are characteristic of Alzheimer’s disease.

NGS (next-generation sequencing) genetic testing can be used to detect mutations in the PSEN1 gene. This type of testing involves sequencing the entire gene to identify any changes or variations in the DNA sequence that may be associated with Alzheimer’s disease. NGS testing can be performed using a blood sample or other tissue sample, and can provide a rapid and accurate diagnosis of genetic disorders like Alzheimer’s disease.